Concomitant |
Product Used For Unknown Indication |
15.6% |
Hypertension |
12.8% |
Drug Use For Unknown Indication |
10.7% |
Dizziness |
10.3% |
Depression |
4.3% |
Prophylaxis |
4.1% |
Constipation |
4.0% |
Insomnia |
4.0% |
Pain |
4.0% |
Hepatitis C |
3.8% |
Asthenopia |
3.5% |
Gastric Ulcer |
3.4% |
Gastritis |
3.3% |
Diabetes Mellitus |
3.1% |
Pancreatic Neuroendocrine Tumour |
2.6% |
Rheumatoid Arthritis |
2.5% |
Cerebral Infarction |
2.1% |
Arteriosclerosis Obliterans |
2.0% |
Psoriasis |
2.0% |
Atrial Fibrillation |
1.9% |
|
Vomiting |
15.9% |
Renal Failure Acute |
12.5% |
Rhabdomyolysis |
6.8% |
Cerebral Infarction |
5.7% |
Pneumonia Aspiration |
5.7% |
Hyperammonaemia |
4.5% |
Interstitial Lung Disease |
4.5% |
Renal Impairment |
4.5% |
Stomatitis |
4.5% |
Tremor |
4.5% |
White Blood Cell Count Decreased |
4.5% |
Blood Potassium Decreased |
3.4% |
Hallucination, Visual |
3.4% |
Optic Neuritis |
3.4% |
Therapeutic Agent Toxicity |
3.4% |
Urine Output Decreased |
3.4% |
Altered State Of Consciousness |
2.3% |
Atrial Fibrillation |
2.3% |
Dehydration |
2.3% |
Drug Eruption |
2.3% |
|